Ivonne Z. Jimenez Velázquez
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 5 | 2016 | 160 | 0.390 |
Why?
|
| Alzheimer Disease | 8 | 2015 | 1001 | 0.380 |
Why?
|
| Developing Countries | 5 | 2016 | 113 | 0.310 |
Why?
|
| Urticaria | 1 | 2008 | 5 | 0.290 |
Why?
|
| Aged | 20 | 2016 | 8214 | 0.190 |
Why?
|
| Aged, 80 and over | 12 | 2016 | 2853 | 0.170 |
Why?
|
| Lewy Body Disease | 2 | 2011 | 16 | 0.160 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 423 | 0.140 |
Why?
|
| Presenilin-1 | 2 | 2015 | 28 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 734 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2015 | 863 | 0.130 |
Why?
|
| Mental Disorders | 2 | 2012 | 392 | 0.120 |
Why?
|
| Open Reading Frames | 1 | 2015 | 79 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 104 | 0.110 |
Why?
|
| Consanguinity | 1 | 2014 | 5 | 0.110 |
Why?
|
| Income | 1 | 2016 | 160 | 0.110 |
Why?
|
| Caribbean Region | 5 | 2015 | 79 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 213 | 0.100 |
Why?
|
| Anemia | 1 | 2012 | 55 | 0.090 |
Why?
|
| Awareness | 1 | 2012 | 73 | 0.090 |
Why?
|
| Male | 16 | 2016 | 23409 | 0.090 |
Why?
|
| Humans | 21 | 2016 | 43102 | 0.090 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 2010 | 4 | 0.080 |
Why?
|
| Female | 16 | 2016 | 24698 | 0.080 |
Why?
|
| Lewy Bodies | 1 | 2011 | 30 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 139 | 0.080 |
Why?
|
| Clusterin | 1 | 2010 | 9 | 0.080 |
Why?
|
| Age of Onset | 4 | 2015 | 114 | 0.080 |
Why?
|
| Mutation | 1 | 2015 | 1177 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 539 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2012 | 243 | 0.080 |
Why?
|
| Community Health Services | 1 | 2011 | 206 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 223 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 22 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 333 | 0.070 |
Why?
|
| Dominican Republic | 3 | 2014 | 20 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 10 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2009 | 80 | 0.070 |
Why?
|
| Puerto Rico | 5 | 2012 | 1413 | 0.070 |
Why?
|
| Contrast Media | 1 | 2008 | 103 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2015 | 1759 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2016 | 3156 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 172 | 0.060 |
Why?
|
| Health Services | 1 | 2006 | 61 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2011 | 590 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2006 | 90 | 0.060 |
Why?
|
| Neuropsychological Tests | 3 | 2012 | 284 | 0.060 |
Why?
|
| Middle Aged | 8 | 2015 | 12222 | 0.060 |
Why?
|
| Neoplasms | 2 | 2009 | 1377 | 0.060 |
Why?
|
| Hypertension | 1 | 2012 | 835 | 0.060 |
Why?
|
| Prevalence | 3 | 2016 | 1612 | 0.050 |
Why?
|
| Orthomolecular Therapy | 1 | 2002 | 3 | 0.050 |
Why?
|
| Latin America | 2 | 2012 | 55 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 74 | 0.040 |
Why?
|
| India | 2 | 2012 | 108 | 0.040 |
Why?
|
| China | 2 | 2012 | 229 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 706 | 0.040 |
Why?
|
| Risk Factors | 3 | 2014 | 3994 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 1067 | 0.040 |
Why?
|
| Genotype | 2 | 2014 | 800 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1285 | 0.040 |
Why?
|
| Antioxidants | 1 | 2002 | 443 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2008 | 61 | 0.030 |
Why?
|
| Apolipoprotein E4 | 2 | 2008 | 67 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 35 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 94 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 72 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 195 | 0.030 |
Why?
|
| Aging | 2 | 2012 | 783 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 150 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 161 | 0.030 |
Why?
|
| Venezuela | 1 | 2012 | 8 | 0.020 |
Why?
|
| Computational Biology | 1 | 2015 | 327 | 0.020 |
Why?
|
| Cuba | 1 | 2012 | 33 | 0.020 |
Why?
|
| Mexico | 1 | 2012 | 298 | 0.020 |
Why?
|
| Financing, Personal | 1 | 2011 | 9 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2011 | 152 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 125 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2010 | 206 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 138 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 291 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 352 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 719 | 0.020 |
Why?
|
| Orientation | 1 | 2008 | 33 | 0.020 |
Why?
|
| Problem Solving | 1 | 2008 | 38 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 509 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2009 | 224 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 55 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1028 | 0.020 |
Why?
|
| Visual Perception | 1 | 2008 | 80 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2008 | 86 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 115 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2008 | 57 | 0.020 |
Why?
|
| Lod Score | 1 | 2007 | 13 | 0.020 |
Why?
|
| Linear Models | 1 | 2008 | 317 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 199 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2008 | 103 | 0.020 |
Why?
|
| Memory | 1 | 2008 | 174 | 0.020 |
Why?
|
| Language | 1 | 2008 | 185 | 0.020 |
Why?
|
| Adult | 3 | 2009 | 13872 | 0.020 |
Why?
|
| United States | 2 | 2009 | 5205 | 0.020 |
Why?
|
| Health Policy | 1 | 2008 | 184 | 0.020 |
Why?
|
| Adolescent | 2 | 2009 | 6081 | 0.020 |
Why?
|
| Incidence | 1 | 2009 | 1078 | 0.010 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2006 | 82 | 0.010 |
Why?
|
| Infant | 1 | 2009 | 1175 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2009 | 1546 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 874 | 0.010 |
Why?
|
| Public Health | 1 | 2008 | 424 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 1604 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 67 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 1234 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 2544 | 0.010 |
Why?
|
| Child | 1 | 2009 | 3443 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5080 | 0.010 |
Why?
|